We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHIL
3251
DELISTED
Benson Hill, Inc.
BHIL
$180K ﹤0.01%
25,605
+483
+2% +$3.31K
SWKH
3252
DELISTED
SWK Holdings
SWKH
$177K ﹤0.01%
12,856
TCRX icon
3253
TScan Therapeutics
TCRX
$48.6M
$176K ﹤0.01%
22,104
IMRX icon
3254
Immuneering
IMRX
$267M
$175K ﹤0.01%
60,512
CUE icon
3255
Cue Biopharma
CUE
$113M
$173K ﹤0.01%
3,051
-472
-13% -$33.3K
VUZI icon
3256
Vuzix
VUZI
$194M
$172K ﹤0.01%
142,266
-26,677
-16% -$43.5K
REAL icon
3257
The RealReal
REAL
$1.46B
$171K ﹤0.01%
43,796
GAIA icon
3258
Gaia
GAIA
$46.8M
$169K ﹤0.01%
54,763
EP icon
3259
Empire Petroleum
EP
$99.1M
$168K ﹤0.01%
32,913
APLT
3260
DELISTED
Applied Therapeutics
APLT
$167K ﹤0.01%
24,504
NVCT icon
3261
Nuvectis Pharma
NVCT
$678M
$163K ﹤0.01%
19,920
BIRD icon
3262
Smartbird Inc
BIRD
$19.5M
$160K ﹤0.01%
11,544
-1,980
-15% -$36.9K
METCB icon
3263
Ramaco Resources Class B
METCB
$425M
$160K ﹤0.01%
13,765
PRTH icon
3264
Priority Technology Holdings
PRTH
$535M
$160K ﹤0.01%
48,838
ESPR
3265
DELISTED
Esperion Therapeutics
ESPR
$155K ﹤0.01%
57,991
INO icon
3266
Inovio Pharmaceuticals
INO
$55.7M
$154K ﹤0.01%
11,075
-1
-0% -$9
ADVM
3267
DELISTED
Adverum Biotechnologies
ADVM
$151K ﹤0.01%
10,713
+7,072
+194% +$108K
GATO
3268
DELISTED
Gatos Silver, Inc.
GATO
$150K ﹤0.01%
17,898
TSHA icon
3269
Taysha Gene Therapies
TSHA
$1.68B
$148K ﹤0.01%
51,462
+35,322
+219% +$73.6K
AKBA icon
3270
Akebia Therapeutics
AKBA
$354M
$146K ﹤0.01%
79,804
SSRM icon
3271
SSR Mining
SSRM
$5.32B
$145K ﹤0.01%
32,619
+1,922
+6% +$13.4K
CLPR
3272
Clipper Realty
CLPR
$45.2M
$143K ﹤0.01%
29,696
VIGL
3273
DELISTED
Vigil Neuroscience
VIGL
$143K ﹤0.01%
41,968
RLYB icon
3274
Rallybio
RLYB
$84.5M
$142K ﹤0.01%
9,627
PRCH icon
3275
Porch Group
PRCH
$1.64B
$142K ﹤0.01%
33,000

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.